Bacil Pharma Ltd

NSE: BACPHAR · BSE: 524516 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.50
Market cap: ₹36.60 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹1.56 Cr
P/E (TTM): 55.8×Sector 47.4×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Date 3 Other Announcement 2 Merger & Restructuring 2 Fund Raise 2 Board Meeting Outcome 2 Financial Results 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Jul 2026 13:20 IST BSE

Fund Raise

Bacil Pharma Fund Raise of ₹50 Cr

Bacil Pharma approved a Rights Issue of up to ₹50 Crore to raise funds. The Board also noted the resignation of two Independent Directors.

Value: ₹50.00 Cr

Read the filing ↗

9 Jul 2026 20:05 IST BSE

Fund Raise

Bacil Pharma Fund Raise of ₹50 Cr

Bacil Pharma's board approved a Rs. 50 Crore fundraise via Rights Issue. The board also increased authorized share capital and accepted resignations of two independent directors.

Value: ₹50.00 Cr

Read the filing ↗